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ABSTRACT
Objectives To examine potential reciprocal associations
between common mental disorders and obesity, and to
assess whether dose-response relations exist.
Design Prospective cohort study with four measures of
common mental disorders and obesity over 19 years
(Whitehall II study).
Setting Civil service departments in London.
Participants 4363 adults (28% female, mean age
44 years at baseline).
Main outcome Common mental disorder defined as
general health questionnaire “caseness;” overweight and
obesity based on Word Health Organization definitions.
Results In models adjusted for age, sex, and body mass
index at baseline, odds ratios for obesity at the fourth
screening were 1.33 (95% confidence interval 1.00 to
1.77), 1.64 (1.13 to 2.36), and 2.01 (1.21 to 3.34) for
participantswithcommonmentaldisorderat one,two, or
three preceding screenings compared with people free
from common mental disorder (P for trend<0.001). The
corresponding mean differences in body mass index at
themostrecentscreeningwere0.20,0.31,and0.50(Pfor
trend<0.001). These associations remained after
adjustment for baseline characteristics related to mental
health and exclusion of participants who were obese at
baseline. In addition, obesity predicted future risk of
common mental disorder, again with evidence of a dose-
responserelation(Pfortrend=0.02,multivariablemodel).
However, this association was lost when people with
commonmentaldisorderatbaselinewereexcluded(Pfor
trend=0.33).
Conclusions These findings suggest that in British adults
the direction of association between common mental
disorders and obesity isfrom common mentaldisorder to
increased future risk of obesity. This association is
cumulative such that people with chronic or repeat
episodes of common mental disorder are particularly at
risk of weight gain.
INTRODUCTION
Common mental disorders, such as depression and
anxiety, have been hypothesised to increase the risk
ofobesity,butthe evidenceisinconclusive.
1Somestu-
diesshowhigherratesofobesityinpeoplewithmental
health problems,
2-5 whereas others report no
association,
6 or even a reverse effect, although this
last has largely been seen in subgroups that offer lim-
ited generalisability.
47As the development of obesity
hasarelativelylonginductionperiod,chronicorrecur-
rent mental disorder is a more plausible cause than
transient mental disorder. However, previous studies
have typically measured common mental disorder at
only one time point.
Other series of studies have explored the opposite
causal direction—that is, obesity as a risk factor for
future mental disorder. Again, the results from these
studies have been contradictory.
8 Some studies find
that people with greater body mass index have an
increased risk of depression and anxiety
disorders,
6910 others report no association of obesity
with these outcomes,
11 and another group of studies
report negative associations (greater obesity being
associated with reduced risk of future mental health
problems and suicide).
1213
Several mechanisms could explain these two causal
directions. The associations between obesity and com-
mon mental disorder may be context specific, depend-
ing on, for example, attitudes towards body size and
mentalillhealth,suchthatthenatureoftheassociations
differs in different populations. That is, in societies in
which obesityisstigmatised,thismayleadtoincreased
risk of anxiety and depression.
14 On the other hand,
stress and common mental disorders themselves are
associated with disordered eating, which could influ-
ence future changes in adiposity,
1516 and commonly
usedtreatmentsfordepressionhave knownside effects
that also could lead to weight gain.
17
Giventhepublichealthimportanceoftheincreasing
ratesofbothobesityandcommonmentaldisorder,
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these two conditions is crucial and could potentially
inform prevention and treatment. Prospective studies
with repeat measurements of both common mental
disorder and obesity offer a unique opportunity for
in-depth study of this, but they are rare. Such studies
have the capacity to explore the possible reciprocal
nature of these associations and determine whether a
dose-response(cumulative)effectexistsineitherdirec-
tion. This study takes advantage of four waves of med-
ical screening from the Whitehall II study of British
government employees to determine the direction
and possible dose-response nature of the association
between common mental disorder and obesity.
METHODS
Study population
The target population of the British Whitehall II study
was all London based office staff, aged 35-55, working
in 20 civil service (government) departments at study
baselinein1985-8.
20Witharesponseof73%,thebase-
line cohort consisted of 10308 employees (6895 men
and 3413 women).
Design
Since the first medical examination (phase 1, 1985-8),
follow-up screenings with a medical examination have
taken place on three occasions over a 19 year period:
phase3(1991-3),phase5(1997-9),andphase7(2003-4).
All these phases included a standardised assessment of
commonmentaldisorder(generalhealthquestionnaire,
describedbelow)anddirectmeasurementofweightand
height from which body mass index was derived.
Baseline characteristics
Demographic characteristics, behavioural risk factors,
andchronichealthconditionsmeasuredwereage,eth-
nicity (white v non-white), marital status (married or
cohabiting v other), socioeconomic position (high,
intermediate, or low, derived from civil service
employment grade), smoking (never smoker, ex-
smoker, 1-10, 11-20, or >20 cigarettes a day), alcohol
consumption (0, 1-21, and >21 units of alcohol a week
for men; 0, 1-14, and >14 units for women), physical
activity (vigorous, moderate, or mild), systolic blood
pressure (mm Hg), diastolic blood pressure (mm Hg),
totalcholesterol(mmol/l),diabetes(selfreported),and
coronary heart disease.
20 Coronary heart disease was
defined by using the multinational monitoring of
trends and determinants in cardiovascular disease
(MONICA) criteria,
21 using responses to questions
about chest pain and diagnoses by physicians, exami-
nation of medical records, and electrocardiography
findings. We considered these variables as potential
confounders or mediating factors in the association
between common mental disorder and obesity.
Common mental disorder
We assessed common mental disorders by using the
self administered 30 item general health
questionnaire,
22 a screening instrument designed for
community settings.It has beenvalidatedagainst stan-
dardisedclinicalinterviews,hasshownhighreliability,
and has been widely used in large population based
surveys and trials and shown high predictive validity
such that people classified as “cases” have raised mor-
tality relative to non-cases.
23
Each general health questionnaire item inquires
about a specific symptom. Response categories are
scoredaseither1or0toindicatewhetherthesymptom
is present or not. On the basis of receiver operating
characteristicsandpreviousstudies,wedefinedpeople
with a total score of 5 or more as general health ques-
tionnaire cases and those scoring 0-4 as non-cases.
24 In
this study, in which the scores were validated against a
clinical interview schedule, sensitivity (73%) and spe-
cificity (78%) measures indicate that this definition of
“caseness” is acceptable.
24 Given that we explored
bidirectional associations between common mental
disorders and obesity, caseness (and obesity) could be
considered an exposure variable or an outcome.
Obesity and overweight
We calculated body mass index as weight (kilograms)/
height (metres) squared. Following the World Health
Organization’s definition, we considered participants
with a body mass index of 25-29.9 to be overweight
Started screening (n=10 308)
Included at phase 1 (n=10 175)
Included at phase 3 (n=7819)
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Excluded (n=133):
  Missing BMI despite attending screening (n=14)
  Non-response to GHQ (n=119)
  Missing BMI or non-response to GHQ (n=133)
Excluded (n=2356):
  Died (n=106)
  Missed screening (n=2053)
  Missing BMI despite attending screening (n=27)
  Non-response to GHQ (n=1848)
  Missing BMI or non-response to GHQ (n=2250)
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Excluded (n=2750):
  Died (n=98)
  Missed screening (n=1659)
  Missing BMI despite attending screening (n=803)*
  Non-response to GHQ (n=1348)
  Missing BMI or non-response to GHQ (n=2652)
Included at phase 5 (n=5069)
Included in primary analysis (n=4363)
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Excluded (n=706):
  Died (n=81)
  Missed screening (n=528)
  Missing BMI despite attending screening (n=18)
  Non-response to GHQ (n=479)
  Missing BMI or non-response to GHQ (n=625)
Flow chart of follow-up. BMI=body mass index; GHQ=general
health questionnaire. *Greater number of participants with
missing BMI at this phase is due to sickness among clinic
personnel
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obese.
25Weightwasmeasuredinunderweartothenear-
est0.1kgonSoehnleelectronicscales.Heightwasmea-
sured in bare feet to the nearest 1 mm by using a
stadiometer with the participant standing erect with his
or her head in the Frankfort plane. Repeatability of the
weight and height measurements over one month (that
is, between participant variability/total (between
+within participant) variability), done for 306 partici-
pants, was 0.99 at the phase 7 screening.
Statistical analysis
To explore potential selection bias, we first compared
baseline characteristics between participants included
intheanalyticalsampleandthoseexcludedbyusingχ
2
test (categorical variables) or t test (continuous traits).
In the analytical sample, we then ran two sets of ana-
lyses to examine the dose-response pattern and direc-
tion of the association between common mental
disorders and obesity. We used Stata 10.1 statistical
software for Windows for all analyses.
Analysis 1: common mental disorder as a risk factor for
subsequent overweight and obesity—We divided partici-
pants into four groups on the basis of the number of
times they were general health questionnaire cases at
thefirstthreemeasurementphases(phases1,3,and5).
We used multinomial logistic regression analysis to
summarisetheassociationbetweenoccurrenceofcase-
ness and body mass index category (<25 (normal
weight), 25-29.9 (overweight), ≥30 (obese)) at the end
of follow-up (phase 7). This method enabled us to
examine whether the association between caseness
and obesity differed from that for overweight. The
multinomial regression analysis produced odds ratios
for being overweight and obese at the last screening
(both compared with a reference of normal weight)
forparticipantswhohadbeengeneralhealthquestion-
nairecasesno,one,two,orthreetimesatthepreceding
screenings.
Analysis 2: obesity as a risk factor for future common men-
tal disorder—In these analyses, we divided participants
into four groups on the basis of the number of times
they were obese at the first three measurement phases
(no, one, two, or three times). We examined the asso-
ciations between occurrence of obesity and general
health questionnaire caseness at the end of follow-up
(phase 7) by using logistic regression analysis.
Inbothanalysis1and2,wefoundnoevidenceofsex
orethnicdifferencesinanyoftheassociationsbetween
general health questionnaire caseness and obesity
(P=0.34-0.98 for all sex and ethnicity interactions).
Therefore, we pooled the data for men and women
and for ethnic groups and made appropriate adjust-
ments in subsequent analyses. In both analyses, we
estimated regression estimates and accompanying
95% confidence intervals firstly without adjustments
and then with control for age, sex, and baseline body
mass index category (analysis 1) or baseline general
health questionnaire caseness (analysis 2). Further
adjustments took into account all baseline characteris-
tics to examine other potential confounding or
mediated effects.
Sensitivity analyses
To test the robustness of our findings, we ran three
types of sensitivity analysis. Firstly, to examine
Table 1 |Comparison of the characteristics of the analytical sample with those of people in
the excluded baseline population. Values are numbers (percentages) unless stated otherwise
Baseline characteristic
Included
(n=4363)
Excluded*
(n=5412)
P for
heterogeneity
Mean (SD) age (years) 44.0 (6.0) 44.4 (6.1) <0.001
Sex:
Men 3122 (71.6) 3416 (63.1) <0.001
Women 1241 (28.4) 1996 (36.9)
Ethnicity:
White 4042 (92.7) 4691 (87.8) <0.001
Non-white 319 (7.3) 651 (12.2)
Marital status:
Married or co-habiting 3341 (76.8) 3826 (72.6) <0.001
Single/divorced/widow 1011 (23.2) 1442 (27.4)
Socioeconomic position:
High 1484 (34.0) 1380 (26.1) <0.001
Intermediate 2256 (51.7) 2418 (45.7)
Low 620 (14.2) 1495 (28.2)
Smoking status:
Never smoked 2303 (53.8) 2566 (48.6) 0.005
Ex-smoker 1454 (34.0) 1671 (31.7)
Light smoker (1-10 cigarettes/day) 198 (4.6) 310 (5.9)
Moderate smoker (11-20 cigarettes/day) 225 (5.3) 475 (9.0)
Heavy smoker (>20 cigarettes/day) 102 (2.4) 255 (4.8)
Alcohol intake:
None 630 (14.5) 1105 (20.6) <0.001
Moderate (1-20 units/week) 3118 (71.9) 3514 (65.6)
Heavy (≥21 units/week) 586 (13.6) 737 (13.8)
Physical exercise:
Mild/none 1159 (26.8) 1747 (32.9) <0.001
Moderate 2177 (50.4) 2525 (47.5)
Vigorous 982 (22.7) 1039 (19.6)
Mean (SD) systolic blood pressure (mm Hg) 122.1(13.9)(n=4359) 123.2(15.0)(n=5402) <0.001
Mean (SD) diastolic blood pressure (mm Hg) 76.2 (9.7) (n=4359) 77.2 (10.4) (n=5402) <0.001
Mean (SD) total cholesterol (mmol/l) 5.88 (1.11) (n=4339) 5.99 (1.20) (n=5366) <0.001
Diabetes:
No 4318 (99.5) 5303 (98.9) 0.001
Yes 22 (0.5) 61 (1.1)
Coronary heart disease:
No 4338 (99.4) 5351 (98.9) <0.001
Yes 25 (0.6) 61 (1.1)
Use of psychotropic drug:
No 4239 (97.2) 5090 (96.2) 0.005
Yes 121 (2.8) 202 (3.8)
GHQ caseness:
No 3199 (73.3) 3848 (72.6) 0.45
Yes 1164 (26.7) 1450 (27.4)
BMI category:
Normal weight 2793 (64.0) 3179 (58.7)
Overweight 1356 (31.1) 1783 (32.9)
Obese 214 (4.9) 450 (8.3) <0.001
BMI (kg/m
2) 24.3 (3.2) 24.8 (3.7) <0.001
BMI=body mass index; GHQ=general health questionnaire (measure of common mental disorder).
*Not including 533 people who died during follow-up from phase 1 to phase 7.
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groups, excluding from the analyses people who were
obeseoroverweightatbaseline(analysis1)andpeople
who were general health questionnaire cases at base-
line (analysis 2). Secondly, to examine whether the
association between caseness and subsequent obesity
wassensitivetothepredefinedbodymassindexcut-off
pointsused,we repeatedanalysis1 usinglinear regres-
sion analysis with continuous body mass index (rather
than the category) as the outcome. Thirdly, to further
explore the impact of selection bias resulting from
missingdata,weusedmultiplemultivariateimputation
and repeated the analyses on the basis of an imputed
sample of all participants who were alive during the
whole study period (n=9775) (see web appendix)
RESULTS
Sample selection and sample characteristics
The figure shows the selection of the sample. Of the
10308participantsatphase1,10175(98.7%)hadcom-
plete data on weight, height, and general health ques-
tionnaire caseness. At the following phase, these data
were available for 7819 participants (77.7% of the
phase 1 participants who had complete data at phase
1 and were alive at phase 3). At phases 5 and 7, the
corresponding figures were 5069 (65.7% of those
alive at phase 5) and 4363 (87.5% of those alive at
phase 7). Our main analysis was based on those 4363
participants (3122 men and 1241 women) who had
complete data on common mental disorders, weight,
and height at baselineand all follow-up measurements
(44.6%ofthebaselinecohortafterexclusionofthe533
participants who died during follow-up).
Themeanageoftheincludedparticipantswithcom-
pletedatawas44.0years,and26.7%metthecriteriafor
general health questionnaire caseness at phase 1
(table 1). A comparison of people included in the ana-
lyses with those excluded because of loss to follow-up
or missing data revealed modest differences, although
statisticalsignificancewasoftenreachedbecauseofthe
large numbers. Participants included were 0.4 years
younger, were less often obese, and had a 0.5 lower
body mass index and a somewhat more favourable
risk factor profile than did excluded participants. We
found no differences in the prevalence of general
healthquestionnairecasenessbetweenthetwogroups,
although the proportion of people on psychotropic
drugtreatmentwas1.0%loweramongtheparticipants
than among the people excluded.
Analysis 1: common mental disorder as a risk factor for
subsequent overweight and obesity
The mean follow-up from phase 1 to phase 7 was 16.5
(range14.6-18.8)years,andthemeanobservationper-
iod over the first three screenings was 11.0 (9.1-13.3)
years.Oftheparticipantsincludedintheanalysis,2379
(54.5%) never met the definition for general health
questionnairecasenessacrossthefirstthreescreenings,
1159 (26.6%) were cases at one screening, 585 (13.4%)
werecasesattwoscreenings,and240(5.5%)werecases
at all three screenings.
Occurrence of general health questionnaire caseness
wasassociatedwithsubsequentobesity(comparedwith
being of normal weight) in a dose-response manner:
unadjustedoddsratioswere1.11(95%confidenceinter-
val 0.90 to 1.36), 1.27 (0.98 to 1.66), and 1.56 (1.10 to
2.21)forcasenessatone,two,andthreescreeningscom-
pared with participants who were case-free (P for
trend=0.004). We found no robust association between
general health questionnaire caseness at the first three
screenings and subsequent overweight in the unad-
justed analysis (P for trend=0.83, data not shown).
Table 2 shows multivariate models for these associa-
tions among the 4154 participants with complete data.
The dose-response association with obesity was robust
to adjustment for a wide range of potential covariates:
age,sex,andbaselinebodymassindexcategory(model
A); plus ethnicity, marital status, socioeconomic posi-
tion, smoking, alcohol intake, physical activity, blood
pressure,total cholesterol, diabetes, coronary heart dis-
ease, and use of psychotropic drugs (model B).
Analysis 2: obesity as a risk factor for future common
mental disorder
Of the 4363 participants, 3727 (85.4%) were not obese
atanyofthethreephases;291(6.7%)wereobeseonce,
175 (4.0%) were obese twice, and 170 (3.9%) were
obese on three occasions. The odds ratios of general
health questionnaire caseness at phase 7 increased
with the number of times participants were obese.
Compared with non-obese people, the odds ratios in
unadjustedanalysisforthosewhowereobeseone,two,
or three times were 1.29 (0.97 to 1.71), 1.35 (0.95 to
1.93),and1.45(1.02to2.06)(Pfortrend=0.004).How-
ever, as shown in multivariate models (table 3), all the
oddsratiosbetweenobesitycategoriesandsubsequent
general health questionnaire caseness were non-
significant when adjusted for covariables, although
the overall trend remained (P for trend=0.01 in
model A and 0.02 in model B).
Sensitivity analyses
We repeated analyses 1 and 2 in subgroups to further
study the temporal order between general health
Table 2 |Multivariate models of association between occurrence of common mental disorder
(GHQ caseness) and subsequent BMI category (n=4154)
No of times GHQ case
at phases 1, 3, and 5 No of participants
Odds ratio (95% CI)
for overweight*
v normal weight
atphase7(modelA†)
Odds ratio (95% CI) for obese*
v normal weight at phase 7
Model A† Model B‡
0 2259 1.00 (reference) 1.00 (reference) 1.00 (reference)
1 1111 1.19 (0.99 to 1.41) 1.33(1.00to1.77) 1.31 (0.98 to 1.76)
2 555 1.32 (1.05 to 1.66) 1.64(1.13to2.36) 1.63 (1.12 to 2.37)
3 229 1.00 (0.71 to 1.40) 2.01(1.21to3.34) 2.01 (1.19 to 3.39)
Test for trend P=0.07 P<0.001 P<0.001
BMI=body mass index; GHQ=general health questionnaire (measure of common mental disorder).
*1518 (36.5%) normal weight; 1938 (46.7%) overweight; 698 (16.8%) obese.
†Adjusted for age, sex, and BMI category at phase 1.
‡As model A, but additionally adjusted for ethnicity, marital status, socioeconomic position, smoking, alcohol
intake, physical activity, systolic blood pressure, diastolic blood pressure, total cholesterol, diabetes, coronary
heart disease, and use of psychotropic drugs at phase 1.
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response relation between occurrence of caseness and
subsequentobesityremainedafterexclusionofpartici-
pants who were obese at phase 1 (n=214, P for
trend<0.001) and those who were overweight
(n=1356, P for trend=0.03). By contrast,in the analysis
to test the reverse direction, the association between
occurrence of obesity and subsequent general health
questionnaire caseness was lost when participants
defined as cases at phase 1 (n=1164) were excluded
from the analysis (P for trend=0.33).
Further testing dealt with the association between
general health questionnaire caseness and subsequent
obesity. Results from the analysis with continuous
body mass index at phase 7 as the outcome were con-
sistent with the main findings using categories of body
mass index. In models adjusted for age, sex, and body
mass index at baseline, mean differences in body mass
index at the fourth study phase were 0.20 (95% confi-
dence interval 0.02 to 0.37), 0.31 (0.09 to 0.54), and
0.50 (0.17 to 0.83) for people defined as general health
questionnaire cases one, two, or three times relative to
those who were never defined as cases (P for
trend<0.001, n=4154). After adjustment for all base-
line covariates and exclusion of obese participants at
phase 1, the corresponding mean differences were
0.19 (0.03 to 0.35), 0.38 (0.16 to 0.59), and 0.40 (0.09
to0.72),againclearlysupportingadose-responseasso-
ciation (P for trend<0.001, n=3957).
We used multiple imputation to repeat the analyses
reportedin table 2 (common mentaldisorderas a pre-
dictorofobesity)onthebasisofallparticipantsaliveat
phase7,atotalof9775people(seewebappendix).The
dose-response association between general health
questionnaire caseness and subsequent obesity was
very similar to that obtained in the complete case ana-
lysis (table 2). Occurrence of caseness was also asso-
ciated with subsequent overweight (P for trend=0.02)
in these analyses.
DISCUSSION
Findings from this well characterised occupational
cohort of more than 4000 men and women provide
evidence that common mental disorder may be a risk
factor for future obesity. Additionally, we found
evidence that this effect seems to be cumulative.
Thus, the odds ratio of being obese at the fourth and
final screening were two times higher for participants
with common mental disorder at all three preceding
screenings than for those who were disorder-free at
all previous screenings. Evidence existed of a dose-
response effect in the association of common mental
disorder with obesity, such that people who had more
episodes of the disorder had a greater risk of obesity.
This dose-response association was independent of a
wide range of mental health related characteristics at
baseline that may be associated with both obesity and
common mental disorder, including initial body mass
index, age, sex, ethnicity, marital status, socioeco-
nomic position, smoking, alcohol intake, physical
activity, blood pressure, cholesterol, diabetes, coron-
ary heart disease, and use of psychotropic drugs. We
saw a similar pattern of associations when we used
body mass index as a continuous variable.
When we examined the association in the opposite
direction (that is, obesity as a risk factor for common
mental disorder), we also found a dose-response asso-
ciation. However, when we removed participants with
common mental disorder at baseline no association of
obesity with future risk of common mental disorder
existed. These results suggest a temporal sequence
frommentaldisordertoobesityinthiscohortofBritish
adults.
Strengths and weaknesses
Randomised controlled trials are important for show-
ing causal effects, but in this case, where the interest is
in the association between long term mental disorder
and obesity, they may not be feasible. In such cases,
observational data provide the best available source
ofevidence,althoughtheycanneverprovidecomplete
proof of causality. For example, even though adjust-
ment for a wide range of covariates had little effect on
our estimates of association, the possibility of residual
confounding cannot be excluded in observational
research.
Despiteahighresponsetothesurvey(range66-88%)
at the successive data collection phases, loss to follow-
up accumulated over the extended time period, as is
inevitable in all long term prospective studies. How-
ever, associations were similar in our complete case
analyses and analyses based on multivariate multiple
imputationdatasets(webappendix).Multivariatemul-
tipleimputation,incommonwithotherproceduresfor
dealing with missing data, assumes similarity in the
associationsbetweentheexposureandoutcomeinpar-
ticipants with and without missing data. This assump-
tion cannot be tested in any real dataset, but among
those with missing data, “missingness” would have to
bemorecommonforpeoplewithbothmentaldisorder
and low body mass index or with both an absence of
mental disorder and high body mass index to create a
spurious association between common mental disor-
der and obesity. We cannot see any reason why this
should be the case.
Table 3 |Multivariate models of association between obesity and subsequent common
mental disorder (GHQ caseness; n=4154)
No of times obese at phases
1, 3, and 5
No of
participants
Odds ratio (95% CI) for GHQ caseness* at phase 7
Model A† Model B‡
0 3557 1.00 (reference) 1.00 (reference)
1 272 1.21 (0.89 to 1.62) 1.21 (0.89 to 1.63)
2 166 1.35 (0.93 to 1.97) 1.36 (0.93 to 1.99)
3 156 1.43 (0.98 to 2.10) 1.39 (0.94 to 2.05)
Test for trend P=0.01 P=0.02
GHQ=general health questionnaire (measure of common mental disorder).
*834 (20.1%) were GHQ cases at phase 7.
†Adjusted for age, sex, and GHQ caseness at phase 1.
‡As model A, but additionally adjusted for ethnicity, marital status, socioeconomic position, smoking, alcohol
intake, physical activity, systolic blood pressure, diastolic blood pressure, total cholesterol, diabetes, coronary
heart disease, and use of psychotropic drugs at phase 1.
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validated standard questionnaire measure of common
mentaldisordersandbydirectmeasurementsofheight
and weight. In community based samples, mental
healthproblemsareoftencharacterisedbyshiftingpat-
terns of symptoms that resist the precise classification
used for clinical populations and capture variations in
mental health rather than diagnosed mental
illnesses.
2627 In order to characterise long term mental
health problems, we calculated the number of times
thateachparticipantmetthecriteriaforcommonmen-
tal disorder over the first three phases of the study. In
doingso,wegaveequalweighttodatafromeachphase
as the purpose was to estimate each participant’s pro-
pensity for common mental disorder over the whole
periodratherthantoestimateproximalordistaleffects
of disorder on obesity.
Two thirds of our cohort were male white collar
workers, potentially reducing the generalisability of
our findings. Furthermore, occupational groups are,
bytheirverynature,healthierthantheirgeneralpopu-
lation,sotherangeofscoresonthegeneralhealthques-
tionnaire test and the range of body mass index
measurements might be narrower. This being the
case, the associations reported here will, if anything,
be an underestimate of the associations in the general
population,whichincludespeoplenotinemployment.
Comparison with previous studies
We are not aware of any other study that has four
repeat measurements of common mental disorders
and direct assessment of weight and height over an
extended follow-up period. These analyses therefore
make a unique contribution to this area of research.
Our findings are in agreement with a recent longitudi-
nal study of elderly people that showed weight gain to
be more common among people with symptoms of
depression than among those who were symptom-
free.
5 Our results are also consistent with those from
another cohort that used two sets of measurements to
explore the bidirectional association between depres-
sion and type 2 diabetes, a condition associated with
raised body mass index.
10 In that study, baseline
depressive symptoms were associated with increased
risk of type 2 diabetes at the second follow-up (two
years later), after removal of people with diabetes at
baseline and adjustment for a wide range of potential
confounding factors. Given that obesity is the major
risk factor for type 2 diabetes, this association would
be anticipated from our results, although the associa-
tion in that study persisted even after adjustment for
bodymassindex,suggestingthatitmaynotbeentirely
mediated through adiposity. Furthermore, in that
cohort, study members with treated type 2 diabetes at
baselinewereatincreasedriskofdepressivesymptoms
two years later, again after removal of those with
depressive symptoms at baseline and adjustment for a
wide range of potential confounding factors, including
body mass index.
10 Interestingly, impaired fasting glu-
cose and untreated diabetes at baseline were not asso-
ciated with risk of depressive symptoms two years
later, raising the possibility that the association of trea-
ted diabetes with future symptoms may be related to
diagnosisofachronicdisease(orthetreatmentinterms
of drugs and dietary restrictions)rather than to obesity
or other specific biological mechanisms underlying
diabetes.Thispossibilityisconsistentwithourfindings
suggesting no real association between obesity and
subsequent common mental disorder.
Meaning of the study
The two sets of analyses provide evidence that com-
mon mental disorder is predictive of subsequent
weight gain and obesity in this population of British
middle aged adults. Evidence of a dose-response rela-
tion also suggests that people with chronic or repeated
episodes of common mental disorder are particularly
at risk of subsequent obesity. By contrast, our findings
do not suggest that obesity leads to common mental
disordersinthispopulation,astheassociationbetween
thetwowasattenuatedwhenstudymemberswhowere
general health questionnaire cases at baseline were
removed from the analysis.
Several plausible explanations exist for the observa-
tion that persistent common mental disorder is a risk
factor for obesity. Firstly, common mental disorders
are associated with eating disorders, both over-con-
sumption and under-consumption, which could influ-
ence future changes in adiposity.
1516 Secondly,
physical inactivity, a major contributing factor to obe-
sity, is more prevalent among people with mental
health problems, and some randomised controlled
trials suggest that exercise reduces depressive
Table 4 |Subgroup analyses testing temporal order between GHQ caseness and obesity
Subcohort at phase 1 and exposure No of participants Odds ratio (95% CI)
Non-obese participants (n= =4149)
Nooftimes GHQ caseatphases1,3,and
5:
Outcome: obese v normal weight at phase 7*
0 2274 1.00 (reference)
1 1101 1.43 (1.03 to 1.99)
2 550 1.81 (1.19 to 2.75)
3 224 2.61 (1.45 to 4.69)
Test for trend P<0.001
Normal weight participants (n= =2793)
NooftimesGHQcaseatphases1,3,and5 Outcome: obese v normal weight at phase 7*
0 1487 1.00 (reference)
1 762 1.39 (0.75 to 2.57)
2 388 2.05 (1.05 to 4.02)
3 156 1.89 (0.71 to 5.06)
Test for trend P=0.03
Participants not GHQ cases (n= =3199)
No of times obese at phases 1, 3, and 5: Outcome: GHQ caseness at phase 7†
0 2746 1.00 (reference)
1 203 1.13 (0.77 to 1.66)
2 126 1.17 (0.72 to 1.88)
3 124 1.18 (0.73 to 1.90)
Test for trend P=0.33
GHQ=general health questionnaire (measure of common mental disorder).
*Adjusted for age, sex, and body mass index at baseline.
†Adjusted for age and sex.
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sion, although in high quality trials the effect is close
to the null.
28 Thirdly, commonly used drug treatments
for mental disorders have known side effects that may
result in weight gain (tricyclic antidepressants), weight
loss (selective serotonin reuptake inhibitors), or both
(short term and long term effects of selective serotonin
reuptake inhibitors).
1729 Fourthly, biological factors,
such as dysregulation of the hypothalamic-pituitary-
adrenocortical axis, may strengthen the link between
mentaldisordersandobesity.
30Forexample,someevi-
dence exists of abnormal concentrations of hormones
of the hypothalamic-pituitary-adrenocortical axis
among obese people with coexisting depressive
symptoms.
31 All these mechanisms are likely to
increase the risk of obesity in a dose-response fashion
such that single episodes of, for example, hormonal
dysregulation would be less likely to increase risk
than would two, three, or more repeated episodes or
than would a continuous chronic disorder.
Unanswered questions
Furtherlongitudinalresearchisnowneededtoconfirm
the generalisability of these findings to wider popula-
tions; to identify major social, behavioural, and biolo-
gical mechanisms underlying the observed
associations;toidentifythetime lagbetweenexposure
and outcome; and to determine whether our findings
aredirectlytransferabletopatientswhomeettheDiag-
nostic and Statistical Manual of Mental Disorders or inter-
national classification of diseases criteria for specific
mental disorders, such as depression. Long term fol-
low-up of randomised controlled trials for the preven-
tion of common mental disorder in vulnerable groups
that look at obesity as an outcome would be helpful in
proving causality, as would mendelian randomisation
studies showing that genetic variants robustly asso-
ciated with common mental disorder are also related
to obesity. If the observed associations are causal, our
findings have important implications for prevention
and treatment. As obesity is a major risk factor for var-
ious chronic conditions and premature death,
19 an
increasedriskofobesityinducedbymentalhealthpro-
blems should be taken into account in the treatment of
persistent common mental disorders.
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